August 11, 2014 / 4:29 PM / 3 years ago

BUZZ- Cardiome Pharma Corp: Revenue jumps

** Specialty pharmaceutical company’s shares up 6.8 pct at $7.64

** The Canadian company’s revenue in the latest quarter jumps to $7.7 million from $107,000 as sales of its new heart drug, Brinavess, continued to rise

** Brinavess, which has won marketing approval in the European Union, Iceland and Norway, is on clinical hold in the United States

** Sales of the company’s blood thinner, Aggrastat, is falling due to generic competition

** In the 12 months to Friday’s close, the company’s stock had more than tripled

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below